CBD

CBD is the second most common cannabinoid from the plant of cannabis.

CBDV

CBDV is a non-psychoactive cannabinoid with anti-convulsant properties like its homolog CBD. It has also other potential therapeutic properties as antitumorigenic, anti-acne and antiemetic effects.

CBN

CBN is a cannabinoid with weak psycho-active properties and some therapeutic potential related to cancer, pain, ALS and eating disorders.

THCV

THCV is a phytocannabinoid analogous to THC.

CBG

CBG is a non-psychoactive cannabinoid with therapeutic potential in cancer, neurodegenerative diseases, anorexia and cachexia , gastrointestinal inflammation, glaucoma, Psoriasis, chronic

Glioblastoma

Glioblastoma is a malignant brain tumor originated in brain cells called astrocytes. Glioblastoma is one of the most promising targets for cannabinoid therapy. Several research groups found anti-tumor properties of cannabinoids in vitro and in vivo studies.

CBGV

CBGV interacts with several receptors and may have anti-inflammatory and analgesic properties but this is still under investigation.

THCA

THCA is a precursor in THC synthesis (decarboxylation). THCA is not psychoactive and has several therapeutic properties.